| [1] Schmiedel JM,Klemm SL,Zheng Y,et al. Gene expression. MicroRNA control of protein expression noise[J] . Science,2015,348(6230):128-132.[2] Romaine SP,Tomaszewski M,Condorelli G,et al. MicroRNAs in cardiovascular disease:an introduction for clinicians[J]. Heart,2015,101(12):921-928.[3] 程 远,吕圭源,陈素红. 浅谈当归制剂降血压的临床 应用[J] . 亚太传统医药,2011,7(4):138-139.[4] 伊 琳,赵 昕,李 屹. 当归对原发性高血压大鼠脑组织基因表达谱的影响[J]. 中国现代医学杂志,2014, 24(11):24-27.[5] 伊 琳,赵 昕,李 屹. 当归对自发性高血压大鼠脑组织 Tnfaip812、Ahsg 及 Tlr3 基因表达的影响[J]. 中国动脉硬化杂志,2013,21(10):891-893.[6] 崔立建,刘瑞霞,王 艳,等. ACE2-Ang (1-7) -Mas 轴的生物学功能及其下游信号通路[J]. 基础医学与临床,2014,34(12):1718-1722.[7] Favre GA,Esnault VLM,van Obberghen E. Modulation of glucose metabolism by the rennin-angiotensin-aldoterone system[J]. Am J Physiol-Endocrinol Matabol,2015,308(6):E435-E449.[8] Manrique C,Lastra G,Sowers JR. New insights into insulin action and resistance in the vasculature[J]. Ann N Y Acad Sci,2014,1311(1):138-150.[9] Yang Z,Kaye DM. Mechanistic insights into the link between a polymorphism of the 3' UTR of the SLC7A1 gene and hypertension[J]. Hum Mutat,2009,30(3):328-333.[10] Shibuya M . Vascular endothelial growth factor and its receptor system:physiological functions in angiogenesis and pathological roles in various diseases[J]. J Biochem,2013,153(1):13-19.[11] Gerber HP ,McMurtrey A,Kowalski J,et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway:requirement for Flk-1/KDR activation[J] . J Biol Chem, 1998,273(46):30336-30343.[12] Kuehbacher A,Urbich C,Zeiher AM,et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis[J]. Circ Res, 2007,101(1):59-68.[13] 钟南山,陆再英.内科学[M].北京:人民卫生出版社,2008:256-276.[14] Moreau P ,Tea BS,Dam TV,et al. Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR[J]. Hypertension,1997,30(3Pt2):720-724.[15] Kobori H ,Ichihara A,Miyashita Y,et al. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy[J]. J Endocrinol,1999,160(1):43-47.[16] Nadruz W. Myocardial remodeling in hypertension[J]. J Hum Hypertens,2015,29(1):1-6.[17] Wang X ,Wang HX,Li YL,et al. MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis[J]. Hypertension,2015,66(4):776-785.[18] Pan Z ,Sun X,Shan H,et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway[J]. Circulation,2012,126(7):840-850.[19] Wei L,Yuan M,Zhou R,et al. MicroRNA-101 inhibits rat cardiac hypertrophy by rargeting Rab1a [J]. J Cardiovasc Pharmacol,2015,65(4):357-363.[20] Yin K,Zhao L,Feng D,et al. Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis[J]. Cell Physiol Biochem,2015,35(6):2451-2462. |
